ELEKTA AB/ADR (OTCMKTS:EKTAY) Sets New 52-Week High at $14.76

Shares of ELEKTA AB/ADR (OTCMKTS:EKTAY) hit a new 52-week high on Thursday . The company traded as high as $14.76 and last traded at $14.75, with a volume of 1558 shares changing hands. The stock had previously closed at $14.64.

A number of research analysts recently weighed in on EKTAY shares. ValuEngine downgraded ELEKTA AB/ADR from a “hold” rating to a “sell” rating in a research note on Thursday. Zacks Investment Research raised ELEKTA AB/ADR from a “hold” rating to a “buy” rating and set a $14.00 price objective on the stock in a research note on Wednesday, October 23rd.

The stock has a 50 day moving average of $13.29 and a two-hundred day moving average of $13.14. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.86 and a current ratio of 1.08. The firm has a market capitalization of $5.60 billion, a P/E ratio of 44.70, a P/E/G ratio of 2.87 and a beta of 0.46.


Elekta AB (publ) provides equipment and software for cancer and brain disorders worldwide. The company offers radiotherapy systems under the Versa HD, Precise Treatment System, and Elekta Compact names; Elekta Infinity, an image-guided radiation therapy (IGRT) system; and Elekta Synergy, a digital accelerator for advanced IGRT.

See Also: Overbought

Receive News & Ratings for ELEKTA AB/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ELEKTA AB/ADR and related companies with MarketBeat.com's FREE daily email newsletter.